Updated May. 10, 2011 at 7:33 a.m.

Premium Lock Inspire reports $17.6M quarterly loss after restructuring

Published: 2011-05-10 07:31:00
Updated: 2011-05-10 07:33:08

Inspire eye drug fails Phase II trials Inspire drug fails Phase II trials Image 1 of 2 · Next Image…

The Raleigh-based pharmaceutical firm, which is in the process of being acquired by drug giant Merck, says losses increased nearly $3 million from a year ago....

Read More
Read More

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders